| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1146/ANNUREV-MED-012510-175505 |
| P698 | PubMed publication ID | 21226616 |
| P2093 | author name string | Giovanni Musso | |
| Maurizio Cassader | |||
| Roberto Gambino | |||
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 361-380 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Annual Review of Medicine | Q567363 |
| P1476 | title | Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes | |
| P478 | volume | 62 |
| Q52374129 | 1H NMR-Based Identification of Intestinally Absorbed Metabolites by Ussing Chamber Analysis of the Rat Cecum. |
| Q93054978 | A Review of the Role of the Gut Microbiome in Personalized Sports Nutrition |
| Q92841706 | A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements |
| Q58052580 | A computational framework to integrate high-throughput ‘-omics’ datasets for the identification of potential mechanistic links |
| Q34629179 | A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome |
| Q29547726 | A metagenome-wide association study of gut microbiota in type 2 diabetes |
| Q44747838 | ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways |
| Q28547423 | Adhesion Potential of Intestinal Microbes Predicted by Physico-Chemical Characterization Methods |
| Q39133827 | Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice |
| Q59798653 | Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling |
| Q57108408 | Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence? |
| Q34425509 | Anatomical localization of commensal bacteria in immune cell homeostasis and disease |
| Q61443654 | Antibiotic treatment triggers gut dysbiosis and modulates metabolism in a chicken model of gastro-intestinal infection |
| Q34642080 | Antibiotics for irritable bowel syndrome: rationale and current evidence |
| Q51143204 | Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota. |
| Q35851354 | Assessing the Intestinal Microbiota in the SHINE Trial. |
| Q37488208 | Association between gut microbiota and diapause preparation in the cabbage beetle: a new perspective for studying insect diapause. |
| Q93136269 | Associations of the microbiome and esophageal disease |
| Q35914076 | Bacterial adaptation to the gut environment favors successful colonization: microbial and metabonomic characterization of a simplified microbiota mouse model |
| Q35134825 | Beneficial modulation of the gut microbiota. |
| Q55163851 | Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome |
| Q47668921 | Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis |
| Q26782354 | Biological and Nutritional Properties of Palm Oil and Palmitic Acid: Effects on Health |
| Q92663489 | Bioregional Alterations in Gut Microbiome Contribute to the Plasma Metabolomic Changes in Pigs Fed with Inulin |
| Q40899510 | Broad scope method for creating humanized animal models for animal health and disease research through antibiotic treatment and human fecal transfer. |
| Q36110548 | CAZyChip: dynamic assessment of exploration of glycoside hydrolases in microbial ecosystems |
| Q92988352 | Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes |
| Q35572939 | Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. |
| Q34391698 | Characteristic changes in microbial community composition and expression of innate immune genes in acute appendicitis. |
| Q64256531 | Characteristics of Gut Microbiota in Sows and Their Relationship with Apparent Nutrient Digestibility |
| Q33569410 | Chlorinated persistent organic pollutants, obesity, and type 2 diabetes |
| Q36695961 | Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression |
| Q36436750 | Choline metabolites: gene by diet interactions |
| Q36476924 | Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes |
| Q33578696 | Chronobiology and obesity: Interactions between circadian rhythms and energy regulation |
| Q46352618 | Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis. |
| Q38204541 | Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes |
| Q33578547 | Commensal bacteria at the interface of host metabolism and the immune system |
| Q49502660 | Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits. |
| Q40364386 | Constipation and Incident CKD. |
| Q28260631 | Constitutive type I interferon modulates homeostatic balance through tonic signaling |
| Q91839857 | Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications |
| Q35971114 | Correlation between diet and gut bacteria in a population of young adults |
| Q35786074 | Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity? |
| Q35108235 | Critical role of interferon-α constitutively produced in human hepatocytes in response to RNA virus infection |
| Q39531172 | Cross-talk Between Host, Microbiome and Probiotics: A Systems Biology Approach for Analyzing the Effects of Probiotic Enterococcus faecium NCIMB 10415 in Piglets. |
| Q37361703 | Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line |
| Q28539797 | Cultivable bacterial microbiota of northern bobwhite (Colinus virginianus): a new reservoir of antimicrobial resistance? |
| Q57941035 | Culturable bacterial microbiota of the stomach of Helicobacter pylori positive and negative gastric disease patients |
| Q41036699 | Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis |
| Q36219804 | Dietary Keratan Sulfate from Shark Cartilage Modulates Gut Microbiota and Increases the Abundance of Lactobacillus spp. |
| Q90028835 | Dietary Patterns Are Associated with Serum Metabolite Patterns and Their Association Is Influenced by Gut Bacteria among Older German Adults |
| Q35795747 | Dietary fibers and cardiometabolic diseases. |
| Q44863682 | Direct fed microbial supplementation repartitions host energy to the immune system. |
| Q88442235 | Discovery of a Kojibiose Phosphorylase in Escherichia coli K-12 |
| Q35105984 | Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial |
| Q27010006 | Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? |
| Q35643422 | Early life microbial colonization of the gut and intestinal development differ between genetically divergent broiler lines |
| Q33904838 | Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. |
| Q36717912 | Effects of Synbiotics on Inflammatory Markers in Patients With Type 2 Diabetes Mellitus |
| Q30431483 | Effects of dietary nutrients on volatile breath metabolites. |
| Q37004077 | Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial |
| Q41696533 | Endotoxemia, nutrition, and cardiometabolic disorders |
| Q92534104 | Endurance exercise and gut microbiota: A review |
| Q55546596 | Enterobacter cloacae administration induces hepatic damage and subcutaneous fat accumulation in high-fat diet fed mice. |
| Q35994085 | Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT. |
| Q36440132 | Enterotoxigenic and non-enterotoxigenic Bacteroides fragilis from fecal microbiota of children. |
| Q34625951 | Epigenomic regulation of host-microbiota interactions |
| Q28071822 | Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes |
| Q57175300 | Experimentally induced metamorphosis in highly regenerative axolotl (ambystoma mexicanum) under constant diet restructures microbiota |
| Q57799919 | Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice |
| Q88996143 | Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice |
| Q38095825 | From gut changes to type 2 diabetes remission after gastric bypass surgeries |
| Q42694363 | From the Cover: Exposure to Oral Antibiotics Induces Gut Microbiota Dysbiosis Associated with Lipid Metabolism Dysfunction and Low-Grade Inflammation in Mice |
| Q47915889 | Functional Classification of the Gut Microbiota: The Key to Cracking the Microbiota Composition Code: Functional classifications of the gut microbiota reveal previously hidden contributions of indigenous gut bacteria to human health and disease |
| Q38582214 | Functional foods as potential therapeutic options for metabolic syndrome. |
| Q21133916 | Functional similarities between pigeon 'milk' and mammalian milk: induction of immune gene expression and modification of the microbiota |
| Q35024458 | Gas and the microbiome |
| Q35742093 | Genetic and environmental control of host-gut microbiota interactions |
| Q37599728 | Genome Sequence of Christensenella minuta DSM 22607T. |
| Q38786129 | Genome-Wide Studies of Type 2 Diabetes and Lipid Traits in Hispanics |
| Q35209720 | Getting started with microbiome analysis: sample acquisition to bioinformatics |
| Q50093331 | Glutaminolysis Promotes Collagen Translation and Stability via α-ketoglutarate Mediated mTOR Activation and Proline Hydroxylation. |
| Q89495109 | Gut Microbiota Composition Is Related to Cardiorespiratory Fitness in Healthy Young Adults |
| Q51144461 | Gut Microbiota and Type 1 Diabetes. |
| Q26822836 | Gut microbes and host physiology: what happens when you host billions of guests? |
| Q38017712 | Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity |
| Q35033105 | Gut microbiome and metabolic diseases. |
| Q35858073 | Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases |
| Q90310328 | Gut microbiota and cardiovascular disease: opportunities and challenges |
| Q38616155 | Gut microbiota and probiotics: Focus on diabetes mellitus |
| Q28533501 | Gut microbiota contributes to the growth of fast-growing transgenic common carp (Cyprinus carpio L.) |
| Q34669782 | Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation |
| Q98290805 | Gut microbiota-derived metabolites in obesity: a systematic review |
| Q35144358 | Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice |
| Q34467203 | Heterogeneity across the murine small and large intestine |
| Q36858061 | Histone deacetylase inhibition and dietary short-chain Fatty acids |
| Q90266641 | Host transcriptome and microbiome interaction modulates physiology of full-sibs broilers with divergent feed conversion ratio |
| Q35923800 | Imbalance of Gastrointestinal Microbiota in the Pathogenesis of Helicobacter pylori-Associated Diseases |
| Q39012899 | Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes? |
| Q37978785 | Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials |
| Q90606204 | Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells |
| Q39104051 | Impact of the Microbiota and Gastric Disease Development by Helicobacter pylori |
| Q26751430 | Impact of the gut microbiota on inflammation, obesity, and metabolic disease |
| Q35585510 | Impacts of gut bacteria on human health and diseases. |
| Q64063028 | Improvement of Colonic Immune Function with Soy Isoflavones in High-Fat Diet-Induced Obese Rats |
| Q97523059 | Increased levels of conjugated bile acids are associated with human bile reflux gastritis |
| Q56363344 | Inflammaging: a new immune-metabolic viewpoint for age-related diseases |
| Q35095134 | Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet |
| Q35523301 | Influence of intestinal microbiota on body weight gain: a narrative review of the literature |
| Q51297728 | Influence of milk fermented with Lactobacillus rhamnosus NCDC 17 alone and in combination with herbal ingredients on diet induced adiposity and related gene expression in C57BL/6J mice. |
| Q34116722 | Inhibition of antigen trafficking through scavenger receptor A |
| Q38068188 | Integration of datasets from different analytical techniques to assess the impact of nutrition on human metabolome |
| Q34397537 | Interactions between the intestinal microbiota and innate lymphoid cells. |
| Q55210356 | Interactions of Gut Microbiota, Endotoxemia, Immune Function, and Diet in Exertional Heatstroke. |
| Q34561786 | Interspecific variations in the gastrointestinal microbiota in penguins. |
| Q43620728 | Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats |
| Q49831832 | Intestinal epithelial Toll-like receptor 4 prevents metabolic syndrome by regulating interactions between microbes and intestinal epithelial cells in mice. |
| Q35863273 | Intestinal microbiota composition after antibiotic treatment in early life: the INCA study |
| Q36694416 | Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity |
| Q34943068 | Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? |
| Q35599821 | Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients? |
| Q91639676 | Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota |
| Q37654881 | LC-MS-based Metabolomics of Xenobiotic-induced Toxicities. |
| Q99237888 | Lactobacillus johnsonii BS15 Prevents Psychological Stress-Induced Memory Dysfunction in Mice by Modulating the Gut-Brain Axis |
| Q35847988 | Low levels of lipopolysaccharide modulate mitochondrial oxygen consumption in skeletal muscle |
| Q35062195 | Mechanisms of obesity-induced gastrointestinal neoplasia |
| Q42281181 | MetaGen: reference-free learning with multiple metagenomic samples |
| Q38162576 | Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. |
| Q36625912 | Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity |
| Q93144409 | Metabolism, bioenergetics and thermal physiology: influences of the human intestinal microbiota |
| Q35793358 | Metabolome progression during early gut microbial colonization of gnotobiotic mice |
| Q30649847 | Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes. |
| Q34996610 | Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. |
| Q35847464 | Microbiome to Brain: Unravelling the Multidirectional Axes of Communication |
| Q36454308 | Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish |
| Q26766623 | Modeling-Enabled Systems Nutritional Immunology |
| Q35581761 | Monosodium L-Glutamate and Dietary Fat Differently Modify the Composition of the Intestinal Microbiota in Growing Pigs |
| Q38177725 | Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation |
| Q34314273 | Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits |
| Q97681333 | NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet |
| Q89547663 | Neonatal microbiota development and the effect of early life antibiotics are determined by two distinct settler types |
| Q64084682 | Non-Nutritive Sweeteners and Their Implications on the Development of Metabolic Syndrome |
| Q39341139 | Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review |
| Q92626616 | OGG1 deficiency alters the intestinal microbiome and increases intestinal inflammation in a mouse model |
| Q36012308 | Obesity Takes Its Toll on Visceral Pain: High-Fat Diet Induces Toll-Like Receptor 4-Dependent Visceral Hypersensitivity |
| Q35665589 | Obesity and the microbiome |
| Q28394129 | Optimizing protocols for extraction of bacteriophages prior to metagenomic analyses of phage communities in the human gut |
| Q36216779 | Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway |
| Q30235154 | Paediatric type 2 diabetes in China-Pandemic, progression, and potential solutions |
| Q28395167 | Perinatal Lead Exposure Alters Gut Microbiota Composition and Results in Sex-specific Bodyweight Increases in Adult Mice |
| Q91638410 | Polysaccharide extracted from WuGuChong reduces high-fat diet-induced obesity in mice by regulating the composition of intestinal microbiota |
| Q42908744 | Potential role of gastrointestinal microbiota composition in prostate cancer risk. |
| Q34255464 | Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome |
| Q46063549 | Prebiotic milk oligosaccharides prevent development of obese phenotype, impairment of gut permeability, and microbial dysbiosis in high fat-fed mice |
| Q37965353 | Prebiotics to manage the microbial control of energy homeostasis |
| Q43479076 | Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. |
| Q36282616 | Probiotics, prebiotics, and synbiotics: gut and beyond |
| Q37258657 | Regulation of CTnDOT conjugative transfer is a complex and highly coordinated series of events |
| Q38229310 | Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology |
| Q33679044 | Relationships between Composition of Major Fatty Acids and Fat Distribution and Insulin Resistance in Japanese. |
| Q43074748 | Response of Intestinal Bacterial Flora to the Long-term Feeding of Aflatoxin B1 (AFB1) in Mice |
| Q36361747 | Rising incidence and challenges of childhood diabetes. A mini review |
| Q34201551 | Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention |
| Q38156623 | Role of Angptl4 in vascular permeability and inflammation |
| Q91796502 | Role of Gut Microbiota in Hepatocarcinogenesis |
| Q35156688 | Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. |
| Q36834123 | Role of intestinal inflammation as an early event in obesity and insulin resistance |
| Q42706747 | Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus |
| Q35801939 | Role of the Gut Microbiome in Obesity and Diabetes Mellitus |
| Q38031937 | Role of the intestinal microbiome in health and disease: from correlation to causation |
| Q37528986 | Smoking- and alcohol habits in relation to the clinical picture of women with microscopic colitis compared to controls |
| Q37734380 | Strain/species identification in metagenomes using genome-specific markers |
| Q35410354 | Streptococcus mitis induces conversion of Helicobacter pylori to coccoid cells during co-culture in vitro |
| Q35014189 | Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation |
| Q89553910 | Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats |
| Q37344975 | Structured variable selection with q-values |
| Q35829936 | Subtractive assembly for comparative metagenomics, and its application to type 2 diabetes metagenomes |
| Q34651315 | Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity |
| Q34980229 | Surface-associated MUC5B mucins promote protease activity in Lactobacillus fermentum biofilms |
| Q26777567 | Synthetic Ecology of Microbes: Mathematical Models and Applications |
| Q35550621 | T2DM: Why Epigenetics? |
| Q58575541 | TRPA1 Antagonists for Pain Relief |
| Q38548027 | Targeting fatty acid metabolism to improve glucose metabolism. |
| Q49804487 | The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome. |
| Q92503133 | The Microbial Metabolite Trimethylamine N-Oxide Links Vascular Dysfunctions and the Autoimmune Disease Rheumatoid Arthritis |
| Q27008309 | The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease |
| Q53540151 | The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: A double-blind, randomized trial. |
| Q52607468 | The cultivable autochthonous microbiota of the critically endangered Northern bald ibis (Geronticus eremita). |
| Q33640646 | The effect of probiotics on immune regulation, acne, and photoaging |
| Q89705022 | The human gastrointestinal microbiota and prostate cancer development and treatment |
| Q38808222 | The human microbiome and metabolomics: Current concepts and applications |
| Q35106510 | The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing |
| Q34533525 | The metabolic and ecological interactions of oxalate-degrading bacteria in the Mammalian gut. |
| Q42588639 | The microbiome - a new frontier of biology |
| Q38065755 | The neonatal gastrointestinal microbiota: the foundation of future health? |
| Q35785593 | The role of breast-feeding in infant immune system: a systems perspective on the intestinal microbiome |
| Q34169396 | The role of environmental factors in modulating immune responses in early life |
| Q35142299 | The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity |
| Q36994006 | The role of gut microbiota on insulin resistance |
| Q34355154 | The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism |
| Q27014922 | The role of the gut microbiome in the pathogenesis and treatment of obesity |
| Q35747472 | The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes |
| Q33847366 | The vagus nerve and the inflammatory reflex--linking immunity and metabolism |
| Q33646579 | Towards an Integrative Understanding of Diet-Host-Gut Microbiome Interactions |
| Q57810328 | Trimethylamine -Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function |
| Q28547375 | Tumor grafting induces changes of gut microbiota in athymic nude mice in the presence and absence of medicinal Gynostemma saponins |
| Q35762623 | USP18 lack in microglia causes destructive interferonopathy of the mouse brain |
| Q91911751 | Ubiquitin fold modifier 1 activates NF-κB pathway by down-regulating LZAP expression in the macrophage of diabetic mouse model |
| Q60950285 | Untargeted Metabolomics of Extracts from Faecal Samples Demonstrates Distinct Differences between Paediatric Crohn's Disease Patients and Healthy Controls but No Significant Changes Resulting from Exclusive Enteral Nutrition Treatment |
| Q37912165 | Xenobiotic metabolomics: major impact on the metabolome |
| Q35926238 | Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: a pilot study |
Search more.